Anpario (LON:ANP) Announces Earnings Results

Anpario (LON:ANP) released its quarterly earnings results on Monday. The company reported GBX 28.40 ($0.37) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Anpario had a net margin of 9.23% and a return on equity of 8.74%.

Anpario Stock Performance

Shares of ANP traded down GBX 7.50 ($0.10) during trading hours on Wednesday, reaching GBX 380 ($4.91). 45,388 shares of the company traded hands, compared to its average volume of 51,843. Anpario has a 1-year low of GBX 229.50 ($2.97) and a 1-year high of GBX 488.55 ($6.32). The stock has a market cap of £64.83 million, a P/E ratio of 20.98 and a beta of 0.58. The stock’s fifty day moving average is GBX 432.58 and its 200 day moving average is GBX 377.46. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15.

Anpario Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, July 25th. Stockholders of record on Thursday, July 10th will be issued a dividend of GBX 8 ($0.10) per share. This is an increase from Anpario’s previous dividend of $3.25. The ex-dividend date is Thursday, July 10th. This represents a dividend yield of 2.09%. Anpario’s payout ratio is presently 60.74%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Canaccord Genuity Group boosted their price objective on Anpario from GBX 380 ($4.91) to GBX 500 ($6.46) and gave the stock a “buy” rating in a research report on Tuesday, January 14th. Shore Capital reaffirmed a “house stock” rating on shares of Anpario in a research report on Monday.

Insider Buying and Selling

In other news, insider Marc Wilson bought 3,778 shares of Anpario stock in a transaction that occurred on Tuesday, April 1st. The stock was purchased at an average cost of GBX 398 ($5.15) per share, with a total value of £15,036.44 ($19,439.48). 30.51% of the stock is owned by company insiders.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.